Barry, A. L.

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 855

Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

Barry, A. L., Pfaller, M. A., Brown, S. D., Espinel-Ingroff, A., Ghannoum, M. A., Knapp, C., Rennie, R. P., Rex, J. H., & Rinaldi, M. G. (2000) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 211

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study

Gavan, T. L., Jones, R. N., Barry, A. L., Fuchs, P. C., Gerlach, E. H., Matsen, J. M., Reller, L. B., Thornsberry, C., & Thrupp, L. D. (1981) · Journal of Clinical Microbiology

Bacterial Identification and Susceptibility TestingClinical Laboratory Practices and Quality Control

Cited by 97